WallStreetZenWallStreetZen

NYSE: BHC
Bausch Health Companies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BHC stock forecasts and price targets.

Forecast return on equity

Is BHC forecast to generate an efficient return?

Company
-197.16%
Industry
300.73%
Market
230.21%
BHC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BHC forecast to generate an efficient return on assets?

Company
4.15%
Industry
164.57%
BHC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BHC earnings per share forecast

What is BHC's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$3.98+310.77%
Avg 2 year Forecast
$4.26+339.32%
Avg 3 year Forecast
$3.58+269.06%
BHC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

BHC revenue forecast

What is BHC's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$10.3B+2.5%
Avg 2 year Forecast
$10.7B+6.71%
Avg 3 year Forecast
$10.6B+5.61%
BHC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BHC earnings growth forecast

How is BHC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
57.91%
Industry
369.93%
Market
43.04%
BHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
BHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
BHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

BHC revenue growth forecast

How is BHC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
1.84%
Industry
130.59%
Market
26.12%
BHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BHC vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
BHC$6.69N/AN/A
SUPN$47.27$63.25+33.82%Strong Buy
HCM$15.45$20.88+35.11%Hold
PRGO$14.93$21.00+40.66%Buy
ANIP$90.23$110.00+21.91%Strong Buy
View Top Pharmaceutical Stocks

Bausch Health Companies Stock Forecast FAQ

What is BHC's earnings growth forecast for 2025-2027?

(NYSE: BHC) Bausch Health Companies's forecast annual earnings growth rate of 57.91% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 369.93%, and while it is forecast to beat the US market's average forecast earnings growth rate of 43.04%.

Bausch Health Companies's earnings in 2025 is $362,000,000.On average, 5 Wall Street analysts forecast BHC's earnings for 2025 to be $1,476,324,692, with the lowest BHC earnings forecast at $1,388,882,697, and the highest BHC earnings forecast at $1,560,061,517. On average, 5 Wall Street analysts forecast BHC's earnings for 2026 to be $1,578,920,828, with the lowest BHC earnings forecast at $1,349,682,006, and the highest BHC earnings forecast at $1,812,939,319.

In 2027, BHC is forecast to generate $1,326,413,543 in earnings, with the lowest earnings forecast at $1,212,405,485 and the highest earnings forecast at $1,458,910,396.

If you're new to stock investing, here's how to buy Bausch Health Companies stock.

What is BHC's revenue growth forecast for 2025-2027?

(NYSE: BHC) Bausch Health Companies's forecast annual revenue growth rate of 1.84% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 130.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.12%.

Bausch Health Companies's revenue in 2025 is $10,029,000,000.On average, 5 Wall Street analysts forecast BHC's revenue for 2025 to be $3,808,913,999,280, with the lowest BHC revenue forecast at $3,685,531,862,922, and the highest BHC revenue forecast at $3,980,092,819,092. On average, 5 Wall Street analysts forecast BHC's revenue for 2026 to be $3,965,272,142,052, with the lowest BHC revenue forecast at $3,798,169,008,426, and the highest BHC revenue forecast at $4,189,064,365,356.

In 2027, BHC is forecast to generate $3,924,515,280,192 in revenue, with the lowest revenue forecast at $3,732,958,029,450 and the highest revenue forecast at $4,131,634,241,826.

What is BHC's forecast return on assets (ROA) for 2025-2028?

(NYSE: BHC) forecast ROA is 4.15%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 164.57%.

What is BHC's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: BHC) Bausch Health Companies's current Earnings Per Share (EPS) is $0.97. On average, analysts forecast that BHC's EPS will be $3.98 for 2025, with the lowest EPS forecast at $3.75, and the highest EPS forecast at $4.21. On average, analysts forecast that BHC's EPS will be $4.26 for 2026, with the lowest EPS forecast at $3.64, and the highest EPS forecast at $4.89. In 2027, BHC's EPS is forecast to hit $3.58 (min: $3.27, max: $3.94).

What is BHC's forecast return on equity (ROE) for 2025-2028?

(NYSE: BHC) forecast ROE is -197.16%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.